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Abstract
Background: Promyelocytic Leukemia (PML) protein can interact with a multitude of cellular
factors and has been implicated in the regulation of various processes, including protein
sequestration, cell cycle regulation and DNA damage responses. Previous studies reported that
misfolded proteins or proteins containing polyglutamine tracts form aggregates with PML,
chaperones, and components of the proteasome, supporting a role for PML in misfolded protein
degradation.
Results: In the current study, we have identified a reactive oxygen species (ROS) dependent
aggregation of PML, small ubiquitin-like modifier 1 (SUMO-1), heat shock protein 70 (HSP70) and
20S proteasomes in human cell lines that have been transiently transfected with vectors expressing
the puromycin resistance gene, puromycin n-acetyl transferase (pac). Immunofluorescent studies
demonstrated that PML, SUMO-1, HSP70 and 20S proteasomes aggregated to form nuclear
inclusions in multiple cell lines transfected with vectors expressing puromycin (puro) resistance in
regions distinct from nucleoli. This effect does not occur in cells transfected with identical vectors
expressing other antibiotic resistance genes or with vectors from which the pac sequence has been
deleted. Furthermore, ROS scavengers were shown to ablate the effect of puro vectors on protein
aggregation in transfected cells demonstrating a dependency of this effect on the redox state of
transfected cells.
Conclusion: Taken together we propose that puromycin vectors may elicit an unexpected
misfolded protein response, associated with the formation of nuclear aggresome like structures in
human cell lines. This effect has broad implications for cellular behavior and experimental design.
Background
The human promyelocytic leukemia PML gene was ini-
tially identified as the fusion partner of the retinoic acid
receptor α gene in the T(15;17) chromosomal transloca-
tion in acute promyelocytic leukemia [1]. The PML pro-
tein localizes to punctate nuclear structures called PML
nuclear bodies (NBs) which are discrete foci (0.1–0.2 μm
diameter) that are present in most mammalian cells. PML
is essential for the formation of PML NBs, however the
bodies themselves are composed of many other proteins
such as SUMO, SP100, CBP and Daxx. SUMO-1 (Small
Ubiquitin like Modifier 1) belongs to a family of ubiqui-
tin like proteins that may be covalently attached to pro-
tein substrates and are typically associated with protein
localization. SUMO modification of PML is required for
NB formation [1,2]. Thus far over 50 proteins have been
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transiently, in PML NBs. Typically the size, localization
and number of PML NBs is well conserved in most cells,
however they are dynamic structures that change size,
position and number in response to stress such as heat
shock, DNA damage and heavy metal exposure [2]. PML
NBs have been implicated in the regulation of many cel-
lular functions including DNA repair, antiviral responses,
apoptosis, proteasomal degradation, senescence and gene
regulation. It is still unclear how PML carries out its func-
tions but it is recognized that the localization of proteins
to NBs is important [3]. It has been suggested that PML
NBs may operate as storage sites for nuclear proteins and/
or act as catalytic surfaces where proteins accumulate to be
post translationally modified [4,5]. It has also been sug-
gested that PML NBs may act as active sites for specific
nuclear functions such as chromatin regulation and tran-
scription [6,7]. PML is nonessential and PML knockout
mice are viable, but the protein has been linked to many
pathological states [8]. In particular, PML has been char-
acterized as a tumor suppressor due to its functions in
apoptosis, genomic stability and senescence [3]. PML NBs
also play a role in neurodegenerative diseases however its
participation is not very well defined. Nevertheless, PML
NBs are often localized in the nuclear inclusions formed
by protein/polyglutamine aggregates in diseases such as
spinocerebrellar ataxia and Huntington's disease [9,10].
Newly synthesized proteins must fold correctly to become
functional molecules. Many events including errors in
transcription, mRNA processing and translation lead to
failure in achieving correct protein conformation [11].
Furthermore, environmental factors such as oxidative,
thermal or osmotic stress can interfere with folding of nas-
cent polypeptides and can damage correctly folded pro-
teins or intermediates [12,13]. Misfolded proteins expose
hydrophobic residues that are normally buried in the pro-
tein's interior leading to protein aggregation. Cells have
evolved 'quality control' systems to minimize protein mis-
folding and prevent protein aggregation. Molecular chap-
erones such as the Heat Shock Proteins (HSP) bind to and
stabilize exposed hydrophobic residues thereby reducing
the likelihood of protein aggregation [14]. Chaperones
such as HSP70 are also believed to assist in refolding mis-
folded proteins. In addition, misfolded proteins are gen-
erally targeted for degradation by the ubiquitin
proteasome system [13]. Proteasomes are multi subunit
complexes that are abundant in the nucleus and cytosol in
all eukaryotic cells that function to degrade unwanted or
damaged proteins. Typically proteins are covalently mod-
ified with one or more ubiquitin molecules that act as a
tag for recognition by the proteasomal complex. Failure of
these quality control systems leads to protein aggregates
which are difficult to unfold and/or degrade and are asso-
ciated with the etiologies of many degenerative diseases
such as amyloidoses, Alzheimer's disease and Parkinson's
disease [14,15].
In the current study we have identified a reactive oxygen
species (ROS) dependent aggregation of proteins (includ-
ing PML), proteasomes and chaperones into nuclear
inclusions in cells lines that have been transfected with
vectors expressing the puromycin resistance gene. This
response is strikingly similar to previously described mis-
folded protein responses and has broad implications for
cellular behavior and experimental design.
Results
During the course of our studies we observed an apparent
relocalization of PML nuclear bodies (NBs) in cell lines
transfected with shRNA vectors targeting specific E3
ligases (MDM2 and CHIP). Surprisingly, we also observed
this effect in cells transfected with control vectors express-
ing non targeting shRNA sequences and those without
DNA inserts (empty vectors). To examine this further,
U2OS cells were transiently transfected with empty vec-
tors using Fugene transfection reagent and immunos-
tained for PML 24 h and 48 h after transfection. PML
localized to discrete foci (11 ± 5 foci per cell) dispersed
throughout the nuclei of non transfected and mock trans-
fected cells (Fig 1A). These foci had the typical size and
appearance of PML NBs [3]. Transfection with pcDNA3.1
Neo or pCMV Neo empty vectors had no apparent effect
on PML localization (Fig 1A). However, cells transfected
with pBABE Puro, pSIREN Puro and pLKO.1 Puro empty
vectors displayed aggregation of PML at multiple nuclear
sites. This aggregation appeared as clustering and/or
clumping of PML, and was apparent 24 h and 48 h after
transfection. To test the generality of this effect, we trans-
fected MCF7 and HeLa cells with these empty vectors.
pCMV Neo and pcDNA3.1 empty vectors had no effect on
PML localization in these cells (data not shown). How-
ever, transfection with pBABE Puro, pSIREN Puro and
pLKO.1 Puro (Fig 1B) resulted in aggregation of PML in
the nuclei of both MCF7 and HeLa cells.
We next aimed to quantify the percentage of transfected
cells in which PML aggregation occurred. To this end,
pEGFP Neo empty vector was cotransfected with pBABE
Puro into U2OS cells, and the cells immunostained for
PML 48 h after transfection. Transfected cells were identi-
fied by EGFP expression. PML localization was not altered
in cells transfected with pEGFP Neo alone (Fig. 2A). In
contrast, pBABE Puro (Fig 2A) empty vectors caused PML
aggregation in EGFP co-expressing cells. Transfection of
pBABE Puro caused PML NB aggregation in 21 ± 6% of
EGFP expressing cells (Fig 2B).
PML aggregates similar to that observed in Figs 1 and 2
have been described previously in association with mis-Page 2 of 10
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ome inhibition, viral protein expression, and in
polyglutamine diseases such as Huntington's and spinoc-
erebrellar ataxias [9,10,16,17]. PML was found coaggre-
gated in these nuclear inclusions with SUMO-1, HSP
chaperones, and proteasomes. We examined SUMO-1,
HSP70, and proteasome localization in cells transfected
with the empty, puromycin-resistance vectors. U2OS cells
were transiently transfected with pBABE Puro or pCMV
Neo (control) empty vectors and immunostained 48 h
later for PML and either HSP70, SUMO-1 or 20S proteas-
omes. HSP70 was detected diffusely in both the nucleus
and cytoplasm of non-transfected and control U2OS cells
(Fig 3A). In pBABE Puro transfected cells, HSP70 was dra-
matically relocalized to both nuclear and cytoplasmic
aggregates. Large nuclear aggregates of HSP70 colocalized
with PML clusters in all cells examined. Smaller, speckled
HSP70 aggregates were also observed throughout the
nuclei of many transfected cells but these usually did not
colocalize with PML aggregates (Fig 3A, lower panel/mag-
nified nuclei). SUMO-1 was detected in distinct nuclear
foci that colocalized with PML in non-transfected and
control cells (Fig 3B). In pBABE Puro transfected cells
SUMO-1 relocalized to regions of PML aggregation, either
colocalized with aggregated PML or in the area immedi-
ately surrounding PML aggregates. Immunostaining using
antibodies against 20S proteasomes demonstrated diffuse
nuclear and cytoplasmic localization in non transfected
and control cells (Fig 3C). In pBABE Puro transfected cells,
20S proteasomes were relocalized to large cytoplasmic
and nuclear aggregates which colocalized with nuclear
PML aggregates (Fig 3C) and HSP70 aggregates in both
the nucleus and cytoplasm (data not shown). Relocaliza-
tion of HSP70, SUMO-1, and 20S proteasomes was also
observed in pLKO.1 Puro and pSUPER Puro transfected
U2OS cells (data not shown). In addition, these vectors
caused a similar relocalization of HSP70, SUMO-1, and
20S proteasomes in MCF-7 and HELA cells (data not
shown). Nucleolar localization of PML has been
described during proteasomal inhibition and thermal
stress [17]. To examine the sub-nuclear localization of
PML, we immunostained pBABE Puro transfected cells for
both PML and Fibrillarin as a nucleolar marker. PML did
not colocalize with Fibrillarin stained regions (nucleoli)
in non transfected or control cells (Fig 3D), and PML
aggregates also did not colocalize with Fibrillarin in
pBABE Puro transfected cells. This indicates the PML
aggregates are not localized in nucleolar regions. In sum-
mary, transfection of pBABE Puro, pSUPER Puro and
pLKO.1 Puro caused aggregation of PML, HSP70, SUMO-
1 and 20S Proteasomes in nuclear regions distinct from
nucleoli.
Next, we wished to address why this effect was specific to
certain vectors but not others. The empty vectors that
caused PML, HSP70, SUMO-1, and 20S proteasome aggre-
gation (pBABE Puro, pLKO.1 Puro and pSUPER Puro) are
retroviral vectors that express the puromycin resistance
gene. The vectors that did not cause this effect (pcDNA3.1
Neo, CMV Neo and pEGFP Neo) are non-retroviral vec-
tors that express the neomycin resistance gene. We ques-
tioned whether this effect could be related to either
retroviral genetic sequences or expression of the puromy-
cin resistance gene, puromycin n-acetyl transferase (pac).
In order to investigate this, we used multiple pBABE vec-
tors which differed only in the selection marker expressed
(Puro, Hygro, Neo, GFP, HcRed). U2OS cells were trans-
fected with these pBABE vectors and immunostained 48 h
later for HSP70 and PML. While pBABE Puro caused PML
and HSP70 coaggregation in transfected cells (as shown in
Figs 1, 2, 3), none of the other pBABE vectors had this
effect (Fig 4A). This suggested that the puromycin resist-
ance gene was responsible for PML and HSP70 aggrega-
tion. Next, we deleted the pac gene sequence from the
pBABE Puro vector and transfected the resultant vector
(named pBABE Puro del) into U2OS cells. Immunostain-
ing for PML and HSP70 demonstrated that neither PML
nor HSP70 were aggregated in cells transfected with
pBABE Puro del (Fig 4B). Collectively, this data demon-
Transfection with pSIREN Puro, pBABE Puro or pLKO.1 Puro v rs causes PML agg egation in multiple cell typesFigur  1
Transfection with pSIREN Puro, pBABE Puro or 
pLKO.1 Puro vectors causes PML aggregation in 
multiple cell types. (A) U2OS cells on glass coverslips 
were transiently transfected with empty vectors using 
Fugene transfection reagent and immunostained for PML 
(red) 48 h after transfection. PML antibodies were detected 
using a rhodamine-x conjugated goat anti mouse IgG. Cell 
nuclei were counterstained with DAPI (blue). Images were 
captured at 100× magnification. (B) MCF-7 and HELA cells 
on glass coverslips were transiently transfected with pCMV 
Neo or pLKO.1 PURO empty vector using Fugene transfec-
tion reagent and immunostained for PML (red) 48 h after 
transfection. PML antibodies were detected using a rhodam-
ine-x conjugated goat anti mouse IgG. Cell nuclei were coun-
terstained with DAPI (blue). Images were captured at 100× 
magnification.Page 3 of 10
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gregation.
In the course of these experiments, we observed that high-
passage U2OS cells were prone to PML aggregation fol-
lowing transfection with Puro-based vectors. However,
when these experiments were repeated in low passage
U2OS cells (<10 passages) we did not detect any aggrega-
tion (n = 3 separate experiments). Cell lines are often
maintained in culture over long periods and are subjected
to frequent passaging and multiple freeze-thaw cycles.
Notably, ROS levels have been reported to increase in cells
maintained in culture for prolonged periods, and multi-
ple studies have linked elevated ROS levels with protein
aggregation and misfolding [13,18,19]. We hypothesized
that oxidative stress/ROS generation in cells maintained
in culture over long periods might influence PML aggrega-
tion in transfected cells. To investigate this, we first com-
pared the level of ROS in high passage and low passage
U2OS cells using a flow cytometry approach based on
H2DCFDA, a cell-permeant indicator for reactive oxygen
species that fluoresces in a quantifiable manner in
response to oxidation levels within the cell. Flow analysis
to detect fluorescent H2DCFDA demonstrated that high
passage U2OS cells contain 2.7 ± 0.69 (n = 3 separate
experiments) fold higher levels of ROS compared to low
passage cells (Fig 5A). Next we investigated whether these
higher levels of ROS may be responsible for the protein
aggregation observed in high passage cells. To this end,
aggregation-prone (high passage) U2OS cells were trans-
fected with pBABE Puro or pEGFP Neo. ROS scavengers,
N-acetyl cysteine (NAC) or catalase, were then added to
the media of transfected cells (15 h later), and the cells
immunostained 48 h after transfection for PML and
HSP70. EGFP expressing cells were quantified as a meas-
ure of tranfection efficiency under each condition. Cells
displaying aggregation of PML/HSP70 were quantified
and values corrected for transfection efficiency. PML/
HSP70 aggregation in NAC and catalase treated cells was
reduced by 80% (Fig 5B). This data suggests that ROS lev-
els enhance PML and HSP70 aggregation in these cells.
Finally, we examined whether transfected cells maintain
protein aggregation after undergoing puromycin selec-
tion. For this, U2OS cells were transfected with pBABE
puro or left non-transfected. Four days later, cells were
placed in media containing puromycin (0–15 μg/mL).
Non-transfected cells were killed at all doses of puromcyin
2 days after treatment. Transfected cells were grown for
two weeks in puromycin in order to select for stable, puro-
resistant cells. Stable cells were seeded on coverslips in the
presence or absence of puromycin and stained 3 days later
for PML and HSP70. Analysis of transfected cells grown in
the absence of puromycin demonstrated these cells do not
display PML and/or HSP70 aggregation (Fig 5C). Simi-
larly, stable resistant cells grown in the presence or
absence of puromycin (3 days), no longer display aggrega-
tion of PML and/or HSP70.
Discussion
In the current study, we have described a ROS sensitive
aggregation of PML, HSP70, SUMO-1 and 20S proteas-
omes into nuclear inclusions in cells transfected with vec-
tors expressing the selection marker gene, puromycin n-
acetyl transferase (pac). Moreover, aggregation of HSP70
and proteasomes was also observed in the cytoplasm of
transfected cells. Cytoplasmic inclusions containing
HSP70 and proteasomes have been previously described
and are associated with aggregates of misfolded proteins
[20-22]. Misfolded proteins generated by either protein
over-expression, mutation, or cellular stress expose hydro-
PML aggregation occurs specifically in transfected cellsFigure 2
PML aggregation occurs specifically in transfected 
cells. pEGFP Neo empty vector was transiently cotrans-
fected with pBABE Puro empty vector in U2OS cells on glass 
coverslips. Cells were immunostained for PML (red) 48 h 
after transfection. PML antibodies were detected using a 
rhodamine-x conjugated goat anti mouse IgG. Cell nuclei 
were counterstained with DAPI (blue). Transfected cells 
were identified by EGFP expression (green). (A) Representa-
tive images of U2OS cells transfected with pEGFP Neo 
empty vector alone or pEGFP/pBABE Puro demonstrating 
PML aggregation in co-transfected cells. Images captured at 
100× magnification. (B) Percentage of co-tansfected EGFP 
positive cells displaying PML aggregation were quantified. 
Percentage represents average ± SEM of five independent 
experiments with 300 cells counted per experiment.Page 4 of 10
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PML aggregates colocalize with HSP70, SUMO-1 and 20S proteasomes in regions distinct from nucleoli in pBABE Puro trans-fected cellsFigure 3
PML aggregates colocalize with HSP70, SUMO-1 and 20S proteasomes in regions distinct from nucleoli in 
pBABE Puro transfected cells. U2OS cells on glass coverslips were transiently transfected with pCMV Neo (Control) or 
pBABE Puro empty vector and immunostained 48 h after transfection. Cell nuclei were counterstained with DAPI (blue). 
Images were captured at 63× (A-C) or 100× (D) magnification. (A) Representative images of cells immunostained for HSP70 
(green) and PML (red). PML and HSP70 antibodies were detected using a rhodamine-x conjugated goat anti mouse IgG and 
Alexa 488 goat anti rabbit IgG respectively. Lower panel displays magnified nuclei (2×) from pBABE Puro transfected cells 
(panel above) in order to display speckled nuclear staining pattern of HSP70 in transfected cells. (B) Representative images of 
cells immunostained for SUMO-1 (green) and PML (red). PML and SUMO-1 antibodies were detected using a rhodamine-x 
conjugated goat anti mouse IgG and Alexa 488 goat anti rabbit IgG respectively. (C) Representative images of cells immunos-
tained for 20S Proteasomes (red) and PML (green). 20S Proteasomes and PML antibodies were detected using a rhodamine-x 
conjugated goat anti mouse IgG and Alexa 488 goat anti rabbit IgG respectively. (D) Representative images of cells immunos-
tained for Fibrillarin (green) and PML (red). PML and HSP70 antibodies were detected using a rhodamine-x conjugated goat 
anti mouse IgG and Alexa 488 goat anti rabbit IgG respectively.
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gates throughout the cell [11]. In the cytoplasm it has
been proposed that these aggregates are transported to the
microtubule organizing center (MTOC) in a microtubule
dependent manner where they coalesce to form aggre-
somes [11,22]. Aggresomes are typically enriched with
chaperones such as HSP70 and proteasomes, and are
thought to be sites of misfolded protein degradation. Sim-
ilarly, nuclear inclusions enriched for chaperones and
proteasomes have been described in cells expressing pro-
teins that contain expanded polyglutamine (polyQ)
repeats [20,23]. In neurodegenerative disorders, such as
Huntington's disease and spinocerebellar ataxias, mutant
proteins (huntingtin and ataxins respectively) containing
expanded polyQ repeats form nuclear inclusions associ-
ated with proteasomes and HSP70 in neuronal cells
[9,20,23]. Notably, many reports have described the pres-
ence of PML and SUMO-1 in these neurodegenerative
nuclear inclusions [9,10,24]. Moreover, nuclear inclu-
sions containing HSP70, proteasomes and PML have been
well characterized in cells overexpressing non-PolyQ
aggregation prone proteins, viral proteins and in cells
treated with proteasomal inhibitors [16,17,25-27]. Col-
lectively, these studies suggest that PML bodies can repre-
sent nuclear aggresomes and potential sites of nuclear
misfolded protein degradation. Based on these previous
studies, we propose that a protein aggregation/misfolded
protein response may account for nuclear aggregation of
PML, HSP70, SUMO1 and proteasomes into nuclear
inclusions in this study. We observe nuclear and cytoplas-
mic aggregates in cells transfected with puro vectors which
are strikingly similar to cellular aggresomes. Previous
studies have shown aggregation of transiently overex-
pressed proteins, however this has not been previously
described in cells transfected with empty vectors [22,25].
Cells transfected with a puro vector and then selected in
puromycin did not display PML/HSP70/proteasome/
SUMO aggregates. This suggests cells with aggregates may
either die, or clear/resolve the aggregates through
autophagy or other mechansisms [27,28].
Our results demonstrate that protein aggregation in cells
transfected with empty puro vectors depends on the pres-
ence of the puromycin-resistance (pac) gene. It is pres-
ently unclear why this effect is specific to pac and why
similar aggregation does not occur upon transfection with
vectors expressing other selection markers. One possible
reason could be that puromycin n-acetyl transferase pro-
tein (PAC) is more aggregation prone than other antibi-
otic resistance proteins. We propose that PAC protein may
colocalize with both nuclear and cytosolic aggregates and
that the presence of proteasomes and chaperones may
represent the cells response to aggregated PAC protein.
However, in the absence of commercially available anti-
bodies specific to PAC, we were unable to confirm this
hypothesis. The composition and the primary structure of
a polypeptide determine to a large extent its propensity to
aggregate. We have used two recently developed bioinfor-
matics software programs as a preliminary approach to
compare the protein sequences of neomycin, puromycin
and hygromycin resistance gene products for aggregation
propensity (data not shown). The software Aggrescan pre-
dicts aggregation hotspots in protein sequences [29].
Using this software we did not detect any apparent differ-
ences in aggregation propensity based on protein
sequence/amino acid content. However, using a second
piece of software, PONDR VL-XT (Molecular Kinetics,
Inc., IN) we have detected that a greater percentage of the
puromycin resistance protein (38%) is naturally disor-
dered compared to hygromycin (25%) and neomycin
(22%) resistance proteins [30]. Disordered regions (DRs)
are entire proteins or regions of proteins which lack a
fixed tertiary structure, essentially being partially or fully
unfolded which have been linked to aggregation propen-
sity [31]. It is tempting to speculate that the percentage of
disorder in PAC may lead to its aggregation; however, it is
presently unclear whether this could contribute to the
observed phenotype. Other potential reasons for aggrega-
tion may include possibly higher expression levels, a
greater sensitivity to ROS damage and/or a higher rate of
degradation for PAC which have been shown to contrib-
ute to aggregation propensity in other studies [19,32]. It
also cannot be ruled out that PAC activity or its interaction
with other native proteins may contribute to protein
aggregation in transfected cells. The specificity of this
effect to pac is of great interest and warrants further study.
During the course of this study, we observed the effect of
puro vectors on protein aggregation in multiple cell types
but not in low passage/newer cells (<10 passages). Many
studies have described the generation of reactive oxygen
species (ROS) in cultured cells and higher levels of ROS
are associated with protein aggregation [13,18,19,33]. We
proposed that older cells may contain higher levels of
ROS which could account for aggregation being limited to
higher passage cells. Initially we identified that high pas-
sage cells have a higher level of intracellular ROS. To
investigate this hypothesis further, we used two scaven-
gers that reduce ROS through different mechanisms. Cat-
alase functions to catalyze the decomposition of H2O2,
the major cellular source of ROS, to water and oxygen.
H2O2 readily passes through cell membranes allowing
extracellular catalase (in cell medium) to drain H2O2 from
cells thereby protecting against extracellular and intracel-
lular H2O2 [18]. N-acetyl cysteine functions to stimulate
expression of endogenous intracellular ROS scavengers,
such as glutathione peroxidase [34]. Both ROS scavengers
blocked protein aggregation in aggregation prone U2OS
cells in this study. Since these scavengers use different
mechanisms to decrease ROS, we consider this strong evi-Page 6 of 10
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cally generated as the byproduct of cellular metabolic
processes and are carefully controlled by cellular antioxi-
dants or scavengers. However, oxidative stress ensues
when an imbalance occurs between ROS generation and
antioxidant defenses in favor of the former. Excessive ROS
leads to oxidation of cellular proteins rendering them less
active, less thermostable and more hydrophobic [13]. It is
possible that overexpressed PAC protein is directly dam-
aged by ROS in these cells, leading to increased hydropho-
bicity and aggregation. Most oxidative damage cannot be
reversed and oxidized proteins are generally removed by
proteasomal degradation. Proteasomal activity is also
impaired by ROS and such inhibition of proteasomes may
also contribute to aggregation in our model [35,36]. Many
aspects of cell culture could account for excessive ROS
generation in these cells. Cell culture media tends to be
pro-oxidant due to components such as ascorbate, flavo-
noids and thiols which undergo rapid oxidation to gener-
ate H2O2 and other ROS [37-39]. Cell media is also often
deficient in many antioxidants and antioxidant precursors
[40,41]. Furthermore, cultured cells are grown at high
oxygen tension levels (15–100 times greater than in vivo)
which can lead to enhanced ROS generation by increased
leakage of electrons from electron transport chains [18].
Finally, an association between ROS generation and the
frequency of freeze-thaw cycles of cells has been identified
[42]. We suggest that continuous culture of cell lines may
render cells more susceptible to oxidative stress and that
this may alter cell behavior.
Conclusion
This study has broad implications for cell experimenta-
tion. Many studies are based on malignant cell lines that
are often maintained in culture and/or frozen over long
periods. Cell lines are generally considered to be more
robust than primary cells which often undergo stress dur-
ing cell culture; however, our study shows that cell lines
can also be susceptible to oxidative stress during pro-
longed culture. Our study clearly shows an alteration in
cell phenotype/behavior in a ROS dependent manner.
The aggregation of critical multifunctional proteins and
complexes such as HSP70, PML and proteasomes into
nuclear inclusions clearly may affect multiple cellular
processes and may lead to inaccurate conclusions in
experimental studies. Cell transfection itself is a critical
component of cell biology studies. Typically DNA vectors
are used without consideration for the effects of resistance
proteins in transfected cells. It is surprising that the puro-
mycin resistance gene can cause these effects in cells how-
ever it is worth noting that this gene expresses a foreign
protein in mammalian cells. We suggest caution when
using puromycin-based DNA vectors, as these vectors may
elicit an unexpected misfolded-protein response that
includes PML, HSP70, SUMO-1, and proteasome coaggre-
gation, and that could alter the outcome or interpretation
of experiments.
Methods
Cells, Reagents and Plasmids
HeLa, MCF-7 and U2OS cells were obtained from ATCC
and were grown in Dulbecco's modified Eagle's medium
(DMEM) supplemented with 10% fetal bovine serum
PML/HSP70 co-aggregation is dependent upon the presence of the pac resistanc  ene sequ nce in puromycin vectorsFigure 4
PML/HSP70 co-aggregation is dependent upon the 
presence of the pac resistance gene sequence in 
puromycin vectors. U2OS cells on glass coverslips were 
transiently transfected with empty vectors and immunos-
tained for HSP70 (green) and PML (red) 48 h after transfec-
tion. PML antibodies were detected using a rhodamine-x 
conjugated goat anti mouse IgG or Cy5 goat anti mouse IgG/
pseudocolored red (pBABE hcRed transfected cells only). 
HSP70 antibodies were detected using Alexa 488 goat anti 
rabbit IgG or Cy5 goat anti rabbit IgG/pseudocolored green 
(pBABE GFP transfected cells only). Cell nuclei were coun-
terstained with DAPI (blue). Images were captured at 100× 
magnification. (A) Representative images of cells transfected 
with multiple pBABE vectors carrying alternative selection 
markers demonstrating absence of PML/HSP70 aggregation. 
(B) Representative images of cells transfected with pBABE 
Puro del demonstrating absence of PML/HSP70 aggregation. 
pBABE Puro del was generated by removal of the pac gene 
sequence from parental vector pBABE PURO.Page 7 of 10
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mL). PBABE Puro, pBABE Hygro, pBABE Neo, pBABE
GFP, pBABE hcRed and pSUPER plasmids were obtained
from Addgene (Cambridge, MA). PLKO.1 Puro plasmid,
N-Acetyl Cysteine, Bovine Catalase and puromycin were
obtained from Sigma Aldrich (St Louis, MO). Fugene-6
transfection reagent was obtained from Roche (Nutley
NJ).
Transient and Stable Transfection
Fugene transfection reagent was equilibrated in serum free
DMEM prior to mixing with vector DNA (2 μg). Fugene/
DNA was incubated at room temperature prior to being
added dropwise to cells. To establish stable cell lines,
media was refreshed on transfected cells 4 days later with
media containing puromycin (0, 1, 5, 10 and 15 μg/mL).
Transfected cells were treated with puromycin, refreshed
every 3 days, for > 2 weeks.
Immunofluorescence
Immunofluorescent staining was performed as previously
described [43]. Briefly, cells were transfected on glass cov-
erslips in 6 well dishes. Cells were fixed in 4% paraformal-
dehyde and then methanol fixed in ice cold methanol.
Coverslips were next blocked and permeabilized in 1%
bovine serum albumin (BSA), 0.1% Triton X-100 in PBS
and then incubated with primary antibodies (1:100 dilu-
tion in PBS/1% BSA for all antibodies except 1:50 dilution
for HSP70) for 1.5 h. Cells were incubated with rhodam-
ine conjugated goat anti-mouse IgG, Cy-5 conjugated goat
anti rabbit or mouse IgG (1:2000 dilution in PBS/1%BSA;
Jackson Immunoresearch, West Grove, PA) and/or Alexa
488 conjugated goat anti rabbit or mouse IgG (Invitrogen,
Eugene, OR) for 1 h with DAPI. Primary antibodies used
were specific against PML (PGM3), PML (H238), SUMO-
1 (FL-101) and Fibrillarin (A-16) (Santa Cruz Biotechnol-
ogy, Santa Cruz, CA); HSP70 (D69) (Cell Signaling Tech-
nology, Danvers, MA) and 20S proteasome mAb (Biomol
International, UK). Fluorescent staining was visualized
using an axiovert 200 fluorescence microscope (Zeiss,
Göttingen, Germany).
Deletion of pac sequence from pBABE Puro
Primers were designed for flanking regions of the pac
sequence in the pBABE Puro plasmid. Deletion of the pac
gene was performed using the Quikchange XL mutagene-
sis kit (Strgatagene, La Jolla, CA) exactly as the manufac-
turer described and the resulting plasmid was renamed
pBABE Puro del. Deletion of the pac sequence was con-
firmed by DNA sequencing of the pBABE Puro del plas-
mid.
Detection of intracellular ROS
Cells were grown to 70% confluency in 35 mm dishes.
Cells were trypsinized and incubated with 25 μM Carboxy
H2DCFDA (Invitrogen, Carlsbad, CA) for 30 min at 37°C
in dark. Cells were next washed with ice-cold PBS. Fluores-
cence was quantified by flow cytometry using a BD FACS-
Canto (BD, Franklin Lakes, NJ). Data was analyzed using
FlowJo 8.8. Geometric Mean fluorescence was used as
average fluorescence value for each population.
PML/HSP70 co-aggregation is dependent upon ROS and is not maintained in puromycin resistant selected cellsFigure 5
PML/HSP70 co-aggregation is dependent upon ROS 
and is not maintained in puromycin resistant 
selected cells. (A) Low passage (<10 passages) and high 
passage U2OS cells were incubated with H2DCFDA and ana-
lyzed by flow cytometry to detect ROS levels. Representa-
tive flow cytometry histogram displaying levels of fluorescent 
H2DCFDA in low passage versus high passage U2OS cells. 
(B) U2OS cells on glass coverslips were transiently trans-
fected with pBABE Puro or pEGFP Neo. ROS scavengers, 
catalase (CAT; 50 μg/mL) or N acetyl cysteine (NAC; 10 
mM), were added to media of transfected cells 15 h after 
transfection. Transfected cells were immunostained for 
HSP70 and PML 48 h after transfection. Cells displaying 
aggregation of PML/HSP70 were quantified and expressed as 
a percentage of EGFP expressing cells. Data represents the 
average ± SEM from 3 independent experiments. Asterisk 
represents p-value < 0.01 compared to cells without ROS 
scavengers (Student T Test). (C) Representative images of 
puromycin selected cells demonstrating the absence of PML/
HSP70 aggregation. U2OS cells were transfected with pBABE 
puro and selected in puromycin as described in materials and 
methods and then immunostained for HSP70 (green) and 
PML (red). PML and HSP70 antibodies were detected using a 
rhodamine-x conjugated goat anti mouse IgG and Alexa 488 
goat anti rabbit IgG respectively. Cell nuclei were counter-
stained with DAPI (blue). Images were captured at 100× 
magnification.Page 8 of 10
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